Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database

摘要

BACKGROUNDAs the population ages, the prevalence of myelodysplastic syndromes (MDS) will increase, and many patients with MDS will require end-of-life (EOL) care. Little is known about the intensity of EOL care received by patients with these malignancies.